Title: Efficacy and Safety of Pembrolizumab in Advanced Gastric and Gastroesophageal
Junction Cancer: A Systematic Review and Meta-Analysis
Version: 5 Date: 17 Feb 2025
Reviewer's report:
The authors have addressed all my concerns. I have no further comments, and I think this
systematic review and meta-analysis is acceptable.
Title: Efficacy and Safety of Pembrolizumab in Advanced Gastric and Gastroesophageal
Junction Cancer: A Systematic Review and Meta-Analysis
Version: 5 Date: 17 Feb 2025
Reviewer's report:
The authors have addressed all my concerns. I have no further comments, and I think this
systematic review and meta-analysis is acceptable.
Please review this paper.
user
Title: Efficacy and Safety of Pembrolizumab in Advanced Gastric and Gastroesophageal
Junction Cancer: A Systematic Review and Meta-Analysis
Version: 5 Date: 17 Feb 2025
Reviewer's report:
The authors have addressed all my concerns. I have no further comments, and I think this
systematic review and meta-analysis is acceptable.
assistant